• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hum Vaccin Immunother . Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice

tetano

Editor, Senior Moderator
Hum Vaccin Immunother


. 2022 Jun 20;2083428.
doi: 10.1080/21645515.2022.2083428. Online ahead of print.
Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice


Abenaya Muralidharan[SUP] 1 2 [/SUP], Caroline Gravel[SUP] 3 [/SUP], Greg Harris[SUP] 4 [/SUP], Anwar M Hashem[SUP] 5 6 [/SUP], Wanyue Zhang[SUP] 1 3 [/SUP], David Safronetz[SUP] 7 [/SUP], Gary Van Domselaar[SUP] 7 [/SUP], Florian Krammer[SUP] 2 [/SUP], Simon Sauve[SUP] 3 [/SUP], Michael Rosu-Myles[SUP] 1 3 [/SUP], Lisheng Wang[SUP] 1 [/SUP], Wangxue Chen[SUP] 4 [/SUP], Xuguang Li[SUP] 1 3 [/SUP]



Affiliations

Abstract

Influenza is a major public health concern causing millions of hospitalizations every year. The current vaccines need annual updating based on prediction of likely strains in the upcoming season. However, mismatches between vaccines and the actual circulating viruses can occur, reducing vaccine effectiveness significantly because of the remarkably high rate of mutation in the viral glycoprotein, hemagglutinin (HA). Clearly, it would be of great interest to determine the potential role of universally conserved epitopes in inducing protective immunity. Here, an antibody against the 14-aa fusion peptide sequence at the N-terminus of the HA2 subunit (Uni-1) was investigated for its ability to elicit antibody-dependent cellular cytotoxicity (ADCC) in vitro and cross-protection against lethal infection in animals. Uni-1, known to neutralize influenza type A (IAV) in vitro, was found to induce strong ADCC against diverse influenza viruses, including human and avian IAVs and both lineages of type B (IBV). The ADCC effects against human IAVs by Uni-1 was comparable to ADCC induced by well-characterized antibodies, F10 and FI6V3. Importantly, mice treated with Uni-1 were protected against lethal challenge of IAV and IBV. These results revealed the versatile effector functions of this universal antibody against markedly diverse strains of both IAV and IBV.

Keywords: Influenza; Uni-1; antibody-dependent cellular cytotoxicity (ADCC); cross-protection; universal antibody.
 
Back
Top